Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Cin 71(3):209–249

Article  Google Scholar 

Huang J, Lok V, Ngai CH et al (2021) Disease burden, risk factors, and recent trends of liver cancer: a global country-level analysis. Liver Cancer 10(4):330–345

Article  PubMed  PubMed Central  CAS  Google Scholar 

Reig M, Forner A, Rimola J et al (2022) BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol 76(3):681–693

Article  PubMed  Google Scholar 

Harimoto N, Yoshizumi T, Inokuchi S et al (2018) Prognostic significance of preoperative Controlling Nutritional Status (CONUT) score in patients undergoing hepatic resection for hepatocellular carcinoma: a multi-institutional study. Ann Surg Oncol 25(11):3316–3323

Article  PubMed  Google Scholar 

Kudo M, Matsui O, Izumi N et al (2014) JSH consensus-based clinical practice guidelines for the management of hepatocellular carcinoma: 2014 update by the liver cancer study group of Japan. Liver Cancer 3(3–4):458–468

Article  PubMed  PubMed Central  Google Scholar 

Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334(11):693–699

Article  PubMed  CAS  Google Scholar 

Shimamura T, Akamatsu N, Fujiyoshi M et al (2019) Expanded living-donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5-5-500 rule - a retrospective study. Transplant Int 32:356–368

Article  CAS  Google Scholar 

Umeshita K, Eguchi S, Egawa H et al (2019) Liver transplantation in Japan: registry by the Japanese Liver Transplantation Society. Hepatol Res 49(9):964–980

Article  PubMed  Google Scholar 

Kamiyama T, Nakanishi K, Yokoo H et al (2012) Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma. World J Surg Oncol. 10:107

Article  PubMed  PubMed Central  Google Scholar 

Hayashi M, Shimizu T, Hirokawa F et al (2011) Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma. Am Surg 77(5):572–578

Article  PubMed  Google Scholar 

Lee YH, Koh YS, Hur YH et al (2018) Effectiveness of the albumin-bilirubin score as a prognostic factor for early recurrence after curative hepatic resection for hepatocellular carcinoma. Ann Hepatobiliary Pancreat Surg 22(4):335–343

Article  PubMed  PubMed Central  Google Scholar 

Chan AWH, Zhong J, Berhane S et al (2018) Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection. J Hepatol 69(6):1284–1293

Article  PubMed  Google Scholar 

Shah SA, Greig PD, Gallinger S et al (2006) Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 202:275–283

Article  PubMed  Google Scholar 

Park JH, Koh KC, Choi MS et al (2006) Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma. Am J Surg 192:29–33

Article  PubMed  Google Scholar 

Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213

Article  PubMed  PubMed Central  Google Scholar 

Johnson PJ, Berhane S, Kagebayashi C et al (2015) Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol 33(6):550–558

Article  PubMed  Google Scholar 

Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients (in Japanese). Nippon Geka Gakkai Zasshi 85:1001–1005

PubMed  CAS  Google Scholar 

Tsilimigras DI, Mehta R, Guglielmi A et al (2020) Recurrence beyond the Milan criteria after curative-intent resection of hepatocellular carcinoma: a novel tumor-burden based prediction model. J Surg Oncol 122(5):955–963

Article  PubMed  Google Scholar 

Yen YH, Liu YW et al (2023) Alpha-fetoprotein combined with radiographic tumor burden score to predict overall survival after liver resection in hepatocellular carcinoma. Cancers (Basel) 15(4):1203

Article  PubMed  PubMed Central  Google Scholar 

Araki K, Harimoto N, Kubo N et al (2020) Functional liver volumetry using Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) predicts post-hepatectomy liver failure in resection of more than one segment. HPB 22(2):318–327

Article  PubMed  Google Scholar 

Taketomi A, Kitagawa D, Itoh S et al (2007) Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute’s experience with 625 patients. J Am Coll Surg 204(4):580–587

Article  PubMed  Google Scholar 

Harimoto N, Shirabe K, Ikegami T et al (2015) Postoperative complications are predictive of poor prognosis in hepatocellular carcinoma. J Surg Res 199(2):470–477

Article  PubMed  Google Scholar 

Liver cancer study group of Japan. General rules for the clinical and pathological study of primary liver cancer, Second English edition, pp34–35, Kanehara& Co., Tokyo, 2003

Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24(2):289–293

Article  PubMed  CAS  Google Scholar 

Kokudo T, Hasegawa K, Matsuyama Y et al (2016) Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion. J Hepatol 65:938–943

Article  PubMed  Google Scholar 

Mano Y, Shirabe K, Yamashita Y et al (2013) Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg 258(2):301–305

Article  PubMed  Google Scholar 

Saito Y, Imura S, Morine Y et al (2021) Preoperative prognostic nutritional index predicts short- and long-term outcomes after liver resection in patients with hepatocellular carcinoma. Oncol Lett 21(2):153

Article  PubMed  CAS  Google Scholar 

Minagawa M, Makuuchi M, Takayama T et al (2003) Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 238(5):703–710

Article  PubMed  PubMed Central  Google Scholar 

Burrel M, Reig M, Forner A et al (2012) Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design. J Hepatol 56:1330–1335

Article  PubMed  Google Scholar 

Takayasu K, Arii S, Kudo M et al (2012) Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines. J Hepatol 56:886–892

Article  PubMed  Google Scholar 

Scaffaro LA, Stella SF, Alvares-Da-Silva MR et al (2015) Survival rates according to barcelona clinic liver cancer sub-staging system after transarterial embolization for intermediate hepatocellular carcinoma. World J Hepatol 7(3):628–632

Article  PubMed  PubMed Central  Google Scholar 

Galle PR, Finn RS, Qin S et al (2021) Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial. Lancet Oncol 22(7):991–1001

Article  PubMed  CAS  Google Scholar 

Samuel M, Chow PKH, Shih-Yen EC, et al. Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma. Cochrane Database Syst. Rev. 2009(1)CD001199.

Lee JH, Lee Y, Lee M et al (2015) A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma. Br J Cancer 113(12):1666–1676

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bruix J, Takayama T, Mazzaferro V et al (2015) Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Oncol 16(13):1344–1354

Article  PubMed  CAS  Google Scholar 

Mazzaferro V, Llovet JM, Miceli R et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10(1):35–43

Article  PubMed  Google Scholar 

Yao FY, Xiao L, Bass NM et al (2007) Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant 7(11):2587–2596

Article  PubMed  CAS  Google Scholar 

Yoh T, Ishii T, Nishio T et al (2023) A Conceptual Classification of Resectability for Hepatocellular Carcinoma. World J Surg 47(3):740–748

Article  PubMed  Google Scholar